JP2014529590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014529590A5 JP2014529590A5 JP2014525142A JP2014525142A JP2014529590A5 JP 2014529590 A5 JP2014529590 A5 JP 2014529590A5 JP 2014525142 A JP2014525142 A JP 2014525142A JP 2014525142 A JP2014525142 A JP 2014525142A JP 2014529590 A5 JP2014529590 A5 JP 2014529590A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- rhob
- composition
- seq
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161522009P | 2011-08-10 | 2011-08-10 | |
| US61/522,009 | 2011-08-10 | ||
| PCT/US2012/050146 WO2013023059A2 (en) | 2011-08-10 | 2012-08-09 | Methods and compositions for the treatment of autoimmune and inflammatory diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014529590A JP2014529590A (ja) | 2014-11-13 |
| JP2014529590A5 true JP2014529590A5 (https=) | 2015-09-24 |
| JP6253580B2 JP6253580B2 (ja) | 2017-12-27 |
Family
ID=47669232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014525142A Expired - Fee Related JP6253580B2 (ja) | 2011-08-10 | 2012-08-09 | 自己免疫および炎症性疾患の治療のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9879092B2 (https=) |
| EP (1) | EP2741771B1 (https=) |
| JP (1) | JP6253580B2 (https=) |
| KR (2) | KR102101478B1 (https=) |
| CN (1) | CN104114184B (https=) |
| AU (1) | AU2012294342B2 (https=) |
| CA (1) | CA2844668C (https=) |
| ES (1) | ES2813415T3 (https=) |
| RU (1) | RU2639540C2 (https=) |
| WO (1) | WO2013023059A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150231215A1 (en) | 2012-06-22 | 2015-08-20 | Randolph J. Noelle | VISTA Antagonist and Methods of Use |
| ES2813415T3 (es) | 2011-08-10 | 2021-03-23 | Lankenau Inst Medical Res | Métodos y composiciones para el tratamiento de enfermedades autoinmunes e inflamatorias |
| US9381244B2 (en) | 2012-09-07 | 2016-07-05 | King's College London | VISTA modulators for diagnosis and treatment of cancer |
| WO2015097536A2 (en) | 2013-12-24 | 2015-07-02 | Janssen Pharmaceutical Nv | Anti-vista antibodies and fragments |
| US11014987B2 (en) | 2013-12-24 | 2021-05-25 | Janssen Pharmaceutics Nv | Anti-vista antibodies and fragments, uses thereof, and methods of identifying same |
| AU2015243261B2 (en) * | 2014-04-10 | 2020-06-25 | Lankenau Institute For Medical Research | Methods and compositions for the treatment of ocular diseases and disorders |
| CA2990360C (en) | 2015-06-24 | 2024-02-13 | Janssen Pharmaceutica Nv | Anti-vista antibodies and fragments |
| WO2017137830A1 (en) | 2016-02-12 | 2017-08-17 | Janssen Pharmaceutica Nv | Anti-vista (b7h5) antibodies |
| KR20230119259A (ko) | 2016-04-15 | 2023-08-16 | 이뮤넥스트, 인크. | 항-인간 vista 항체 및 이의 용도 |
| WO2018213331A1 (en) * | 2017-05-16 | 2018-11-22 | Lankenau Institute For Medical Research | Compositions comprising ligands to rhob protein and the uses thereof |
| KR102276941B1 (ko) * | 2018-07-03 | 2021-07-14 | 서울대학교산학협력단 | 류마티스 관절염 치료용 펩티드 및 그의 용도 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2118508A1 (en) * | 1992-04-24 | 1993-11-11 | Elizabeth S. Ward | Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| US6458783B1 (en) | 1997-09-29 | 2002-10-01 | Bristol-Myers Squibb Company | Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase |
| AU735366B2 (en) | 1997-09-29 | 2001-07-05 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
| US5962672A (en) * | 1998-09-18 | 1999-10-05 | Isis Pharmaceuticals Inc. | Antisense modulation of RhoB expression |
| US20050032733A1 (en) | 2001-05-18 | 2005-02-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA) |
| US6979556B2 (en) | 2000-12-14 | 2005-12-27 | Genentech, Inc. | Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes |
| US7795218B2 (en) | 2001-04-12 | 2010-09-14 | Bioaxone Therapeutique Inc. | ADP-ribosyl transferase fusion variant proteins |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| JP4200100B2 (ja) | 2001-11-07 | 2008-12-24 | アジェンシス，インコーポレイテッド | 癌の処置および検出において有用な１６１ｐ２ｆ１０ｂと称される、核酸および対応タンパク質 |
| WO2005017160A2 (en) | 2003-08-13 | 2005-02-24 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
| JP4967137B2 (ja) * | 2005-04-18 | 2012-07-04 | 国立大学法人浜松医科大学 | 癌治療用組成物 |
| US20070213354A1 (en) | 2006-03-08 | 2007-09-13 | Amplimed Corporation | Compositions and Methods for the Treatment of Multiple Sclerosis |
| RU2489166C2 (ru) * | 2006-04-09 | 2013-08-10 | Джинентех, Инк. | Применение антитела для лечения аутоиммунных заболеваний у пациента с неадекватным ответом на ингибитор tnf-альфа |
| JP5354634B2 (ja) * | 2007-01-25 | 2013-11-27 | 国立大学法人大阪大学 | ヒトａｂｈ８タンパク質、それをコードする遺伝子、およびこれらの治療的又は診断的用途 |
| EP2221063A1 (en) | 2009-02-20 | 2010-08-25 | Ganymed Pharmaceuticals AG | Methods and compositions for diagnosis and treatment of cancer |
| US8673314B2 (en) * | 2009-05-26 | 2014-03-18 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| SG195100A1 (en) | 2011-07-01 | 2013-12-30 | Bayer Ip Gmbh | Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors |
| ES2813415T3 (es) | 2011-08-10 | 2021-03-23 | Lankenau Inst Medical Res | Métodos y composiciones para el tratamiento de enfermedades autoinmunes e inflamatorias |
| TW201406707A (zh) | 2012-05-04 | 2014-02-16 | Acucela Inc | 用以治療糖尿病性視網膜病變及其他眼部疾病之方法 |
| AU2015243261B2 (en) * | 2014-04-10 | 2020-06-25 | Lankenau Institute For Medical Research | Methods and compositions for the treatment of ocular diseases and disorders |
-
2012
- 2012-08-09 ES ES12821568T patent/ES2813415T3/es active Active
- 2012-08-09 KR KR1020147006215A patent/KR102101478B1/ko active Active
- 2012-08-09 WO PCT/US2012/050146 patent/WO2013023059A2/en not_active Ceased
- 2012-08-09 KR KR1020207010387A patent/KR102221068B1/ko active Active
- 2012-08-09 AU AU2012294342A patent/AU2012294342B2/en active Active
- 2012-08-09 US US14/237,706 patent/US9879092B2/en active Active
- 2012-08-09 RU RU2014106933A patent/RU2639540C2/ru not_active IP Right Cessation
- 2012-08-09 CA CA2844668A patent/CA2844668C/en active Active
- 2012-08-09 CN CN201280049868.XA patent/CN104114184B/zh not_active Expired - Fee Related
- 2012-08-09 EP EP12821568.8A patent/EP2741771B1/en active Active
- 2012-08-09 JP JP2014525142A patent/JP6253580B2/ja not_active Expired - Fee Related
-
2017
- 2017-12-14 US US15/841,416 patent/US20180094076A1/en not_active Abandoned
-
2020
- 2020-09-03 US US17/011,852 patent/US12545744B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014529590A5 (https=) | ||
| CN111518214B (zh) | 靶向cldn18.2的双特异性抗体及其制备方法和应用 | |
| JP2020508655A5 (https=) | ||
| JP2021510710A5 (https=) | ||
| JP2017504578A5 (https=) | ||
| JP2018121657A5 (https=) | ||
| JP2017523984A5 (https=) | ||
| JP2012501669A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| RU2019120720A (ru) | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином | |
| CN111635458A (zh) | 靶向Sirpα的抗体或其抗原结合片段及其制备和应用 | |
| JP2016536322A5 (https=) | ||
| PE20110225A1 (es) | Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5 | |
| HRP20200390T1 (hr) | Monoklonska antitijela protiv humanog antigena starenja b stanica (bcma) | |
| WO2022166940A1 (en) | Cldn18.2/cd3 bispecific antibodies for the therapy of cldn18.2-expressing solid tumors | |
| JP2023551027A5 (https=) | ||
| JP2016507523A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| HRP20240415T1 (hr) | Kimerni antigenski receptori antigena kapa mijeloma i njihova upotreba | |
| JP2020108395A (ja) | 凝固第ｖｉｉｉ因子（ｆｖｉｉｉ）機能代替活性を有する物質を中和する抗体 | |
| JP2021502984A5 (https=) | ||
| IL273401B1 (en) | Novel antibodies against human leukocyte antigens type A2 and their uses | |
| JP2020515277A5 (https=) | ||
| KR20170084030A (ko) | Fviii의 반응성을 측정하는 방법 | |
| JP2022500455A5 (https=) |